FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

18079811000001102: Methylphenidate 20mg tablets (Kent Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Nov 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1849341000001115 Methylphenidate 20mg tablets (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1849351000001117 Methylphenidate 20mg tablets (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62163501000001118 Methylphenidate 20mg tablets (Neolab Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
62163601000001119 Methylphenidate 20mg tablets (Neolab Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
66288701000001117 Methylphenidate 20mg tablets (Fannin UK Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
73965701000001116 Methylphenidate 20mg tablets (Kent Pharmaceuticals Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Methylphenidate 20mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Methylphenidate 20mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Methylphenidate 20mg tablets (Kent Pharma (UK) Ltd) Is a Product containing precisely methylphenidate hydrochloride 20 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Methylphenidate 20mg tablets (Kent Pharma (UK) Ltd) Has active ingredient Methylphenidate hydrochloride false Inferred relationship Existential restriction modifier
Methylphenidate 20mg tablets (Kent Pharma (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Methylphenidate 20mg tablets (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Methylphenidate 20mg tablets (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Methylphenidate 20mg tablets (Kent Pharma (UK) Ltd) Has specific active ingredient Methylphenidate hydrochloride true Inferred relationship Existential restriction modifier
Methylphenidate 20mg tablets (Kent Pharma (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Methylphenidate 20mg tablets (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Methylphenidate 20mg tablets (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Methylphenidate 20mg tablets (Kent Pharma (UK) Ltd) 30 tablet 3 x 10 tablets Has AMP True Methylphenidate 20mg tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start